AIAxios Techabout 9 hours ago
AI Drug Development Impact Called Disappointing
1 min read
A peer-reviewed paper in Nature Reviews Drug Discovery finds AI's clinical impact on drug development is 'disappointingly limited.' While AI excels at identifying drug candidates, it has not significantly improved their success rate in human trials.
Level
Hype check
Tap to vote and see what everyone thinks.
